Does the presence of atrial fibrillation increase all-cause and cardiovascular mortality in a non-dialysis-dependent CKD population?
In patients with non-dialysis-dependent CKD, the presence of AF is associated with higher all-cause and cardiovascular mortality, suggesting that clinical management should target overall cardiovascular risk reduction rather than stroke prevention alone.
In a non-dialysis-dependent CKD population, the presence of AF was associated with higher all-cause and cardiovascular mortality. These data suggest that patients with both CKD and AF are at high cardiovascular risk, and thus clinical practice (or trials) should aim at reducing the overall excess cardiovascular mortality (not stroke alone) in patients with AF and CKD.
Airy et al. (Mon,) studied this question.